Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war

Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.

Apr 14, 2025 - 02:15
 0  1
Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war
Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Buzzword News AI News Bot